Spanish Registry of Cardioneuroablation (SRCNA)

November 11, 2026 updated by: Teresa Barrio, Fundación de investigación HM

Spanish multicenter registry of cardioneuroablation (ablation of cardiac ganglionated plexi) in patients with reflex syncope and functional bradyarrhythmias Background Cardioneuroablation (CNA) is the catheter ablation of the ganglionated plexi (GP) of the intrinsic cardiac autonomic nervous system, located in the atrial epicardial fat, to reduce parasympathetic tone on the sinus node and the atrioventricular (AV) node. It has been proposed as an alternative to pacemaker implantation in patients, often young, with cardioinhibitory reflex syncope or vagally mediated bradyarrhythmias. However, the available evidence comes mainly from single-center series at highly experienced centers, with heterogeneous techniques (choice of atrium, number of GP targeted, localization method, type of anesthesia) and no standardized acute procedural endpoint. Data from real-world clinical practice are needed to define its efficacy and safety, and to identify which patients and which procedural strategies are associated with better outcomes.

Objectives Primary: to assess syncope recurrence after CNA in real-world clinical practice in Spain.

Secondary: 1) to describe the procedural characteristics and complications of CNA; 2) to identify clinical and procedural predictors of success; 3) to evaluate the change in syncope and presyncope burden and the need for pacemaker implantation during follow-up.

Design Observational, multicenter, ambispective, ongoing registry with 27 participating hospitals in Spain. Cases performed since June 2018 are collected retrospectively, and prospective enrollment of consecutive patients has been in place since April 2021.

Study population

Inclusion criteria: consecutive patients undergoing CNA for syncope with one of the following phenotypes:

  • Cardioinhibitory reflex syncope: bradycardia <40 bpm or asystole documented on tilt testing, Holter monitoring or implantable loop recorder.
  • Mixed reflex syncope: blood pressure drop preceding the heart rate drop on tilt testing.
  • Functional sinus node dysfunction.
  • Functional AV block. Procedure

CNA is performed according to the usual practice of each center. The operator chooses:

  • the approach (right atrium, left atrium or both);
  • the number of GP targeted;
  • the GP localization method (anatomical, fragmented electrograms, high-frequency stimulation, extracardiac vagal stimulation or combinations);
  • the type of anesthesia (general anesthesia, deep sedation, conscious sedation). Data collected
  • Baseline: demographics, body mass index, cardiovascular history and structural heart disease, type of syncope, number of syncopal and presyncopal episodes before CNA, and diagnostic tests (tilt testing, Holter, implantable loop recorder, atropine test).
  • Procedural: approach, GP targeted, localization method, type of anesthesia, ablation catheter and navigation system, RF power and number of applications, procedure and fluoroscopy times, heart rate before and after CNA and response to atropine after the procedure.
  • Safety: procedure-related complications, including sinus node dysfunction, inappropriate sinus tachycardia and vascular complications.
  • Follow-up: syncope and presyncope recurrence, number of episodes per year, need for pacemaker implantation and other clinical events.

Endpoints Primary endpoint: first syncope recurrence after CNA. Secondary endpoints: procedure-related complications; number of syncopal and presyncopal episodes per year before and after CNA; pacemaker implantation during follow-up.

Ongoing sub-studies:

  1. long-term follow-up of these patients and identification of predictors of recurrence;
  2. redo procedures, in patients requiring more than one CNA;
  3. patients followed with an implantable loop recorder (subcutaneous Holter). Expected relevance This registry will provide multicenter real-world data on CNA in Spain. It will help to identify the patients most likely to benefit from the procedure and the technical aspects associated with success, and will generate hypotheses for future randomized trials.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Albacete, Spain
        • Recruiting
        • Hospital Albacete
      • Alicante, Spain
        • Recruiting
        • Hospital General Alicante
        • Contact:
      • Badajoz, Spain
        • Recruiting
        • Hospital Badajoz
      • Barcelona, Spain
      • Barcelona, Spain
        • Recruiting
        • Hospital Vall d´Hebron
      • Bilbao, Spain
        • Recruiting
        • Hospital de Basurto
        • Contact:
      • Córdoba, Spain
        • Recruiting
        • Hospital Reina Sofia
      • Girona, Spain
        • Recruiting
        • Hospital Josep Trueta
      • Granada, Spain
        • Recruiting
        • Hospital Virgen de las Nieves
      • Granada, Spain
      • Huelva, Spain
        • Recruiting
        • Hospital Juan Ramón Jiménez
      • Madrid, Spain
        • Recruiting
        • Hospital Puerta de Hierro
        • Contact:
      • Madrid, Spain
        • Recruiting
        • Hospital 12 de Octubre
        • Contact:
          • Alvaro Marco, amarco89@hotmail.com
      • Madrid, Spain
        • Recruiting
        • Hospital Fundación Jiménez Díaz
      • Madrid, Spain
        • Recruiting
        • Hospital Gregorio Marañon
      • Madrid, Spain
      • Madrid, Spain
      • Navarro, Spain
        • Recruiting
        • Hospital Universitario de Navarra
        • Contact:
      • Santander, Spain
        • Recruiting
        • Hospital Valdecilla
      • Santiago de Compostela, Spain
      • Valencia, Spain
        • Recruiting
        • Hospital La Fe
      • Valladolid, Spain
        • Recruiting
        • Hospital Valladolid
      • Vigo, Spain
        • Recruiting
        • Hospital Álvaro Cunqueiro
      • Vitoria-Gasteiz, Spain
        • Recruiting
        • Hospital Txagorritxu
      • Zaragoza, Spain
        • Recruiting
        • Hospital Miguel Servet
    • Madrid
      • Madrid, Madrid, Spain, 28660
        • Recruiting
        • Hospital HM Monteprincipe
        • Contact:
      • Madrid, Madrid, Spain

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients treated with cardioneuroablation

Description

Inclusion Criteria:

  • patients treated with cardioneuroablation

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
syncope
Time Frame: From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)

recurrence of syncope

From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: During procedure and 3 months after

Complications

During procedure and 3 months after

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2031

Study Registration Dates

First Submitted

November 6, 2026

First Submitted That Met QC Criteria

November 11, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 11, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • SEC2021
  • Spanish Society of Cardiology (Other Grant/Funding Number: Cardiac Rhythm society)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.